9FB-26831-71186
5 vaccinations
12 coded responses
48 check-ins
12 free-text entries
5 call cases
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 341 / FL
- Registered
- 2021-01-17
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-15
Dose 1 — Moderna
-
2021-01-17
Registered in v-safe
- 2021-01-18
-
2021-01-21
Survey response — days 1–6 daily, dose 1MedDRA: Injection site pruritus, Injection site urticaria — Feeling: Good · Site: Itching · Rash, not including the immediate area around the injection siteFree text: Hives 2-3 itchy 1 inch from injection site.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-22
- 2021-01-29
- 2021-02-05
- 2021-02-12
-
2021-02-16
Dose 2 — Moderna
-
2021-02-19
Survey response — days 1–6 daily, dose 2MedDRA: Anxiety, Pre-existing disease — Feeling: Fair · Site: Pain, Swelling · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Slight increase in anxietyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-20
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
- 2021-02-21
-
2021-02-22
Survey response — days 1–6 daily, dose 2MedDRA: Injection site pruritus, Self-medication — Feeling: Good · Site: ItchingFree text: Itching other than at the injection site. Response is good to 1% hydrocortisone ointment.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-23
- 2021-03-02
- 2021-03-09
- 2021-03-16
- 2021-03-23
- 2021-03-30
- 2021-05-18
- 2021-08-17
-
2021-09-17
Dose 3 — Moderna
-
2021-10-26
Survey response — day 35, dose 3MedDRA: Exudative retinopathy, Eye haemangioma, Myositis, Temporomandibular joint syndrome — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Inflation in deltoid and TMJ Coats syndrome w/ hemangioma in Rt. EyeMedDRA releases: 2024-11 · check-in free text available
-
2021-10-26
Report sent to call center — day 35, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2021-10-28
- 2021-10-29
- 2021-12-17
- 2022-03-18
-
2022-05-13
Dose 4 — Moderna
-
2022-05-14
Survey response — days 1–6 daily, dose 4MedDRA: Dizziness — Feeling: Fair · Site: Pain, Itching · Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Mildly lightheadedMedDRA releases: 2024-11 · check-in free text available
- 2022-05-15
- 2022-05-16
- 2022-05-17
- 2022-05-18
- 2022-05-19
- 2022-05-20
- 2022-05-27
- 2022-06-03
-
2022-06-10
Survey response — day 28, dose 4MedDRA: Eye haemorrhage, Office visit, Retinal aneurysm — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Symptoms: Aneurysm in right eye. New hemorrhaging from it. · Healthcare visit (other): Discovered at monthly retinal checkin.MedDRA releases: 2024-11 · check-in free text available
-
2022-06-10
Report sent to call center — day 28, dose 4Get care from a doctor or other healthcare professional1 call case(s)
- 2022-06-13
- 2022-06-13
-
2022-06-13
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-06-13
Call successfulNot applicable - Accidental Reporting
- 2022-06-17
-
2022-06-24
Survey response — day 42, dose 4MedDRA: Irritable bowel syndrome, Office visit — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: IBS-mixed · Healthcare visit (other): Doctors officeMedDRA releases: 2024-11 · check-in free text available
-
2022-06-24
Report sent to call center — day 42, dose 4Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2022-06-27
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2022-08-12
-
2022-09-30
Dose 5 — Moderna
-
2022-10-02
Survey response — days 1–6 daily, dose 5MedDRA: No adverse event — Feeling: Good · Site: Pain, Swelling · Be unable to do your normal daily activitiesFree text: NoMedDRA releases: 2024-11 · check-in free text available
- 2022-10-03
-
2022-10-04
Survey response — days 1–6 daily, dose 5MedDRA: No adverse event — Feeling: Good · Site: PainFree text: NoMedDRA releases: 2024-11 · check-in free text available
- 2022-10-05
- 2022-10-06
-
2022-10-07
Survey response — day 7, dose 5MedDRA: No adverse event — Feeling: GoodFree text:MedDRA releases: 2024-11 · check-in free text available
- 2022-10-14
- 2022-10-21
-
2022-10-28
Survey response — day 28, dose 5MedDRA: Diarrhoea, Pyrexia, SARS-CoV-2 test negative — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Low grade fever of unknown origin for about 6 days. Tested for Covid. It was negative. No other symptoms other than one episode of diarrhea that resolved in 4 hours.MedDRA releases: 2024-11 · check-in free text available
-
2022-10-28
Report sent to call center — day 28, dose 5Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-10-31
- 2022-11-04
- 2022-11-11
-
2022-12-30
Survey response — 3 months, dose 5MedDRA: Unevaluable event, White blood cell count increased — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Symptoms: Elevated white blood count but I don't believe it's related to the vaccine in any way. · Healthcare visit (other): Follow up blood workMedDRA releases: 2024-11 · check-in free text available
-
2022-12-30
Report sent to call center — 3 months, dose 5Get care from a doctor or other healthcare professional1 call case(s)
- 2023-01-03
- 2023-01-03
-
2023-01-03
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2023-01-03
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2023-04-02
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-15 | Moderna | |
| 2 | 2021-02-16 | Moderna | |
| 3 | 2021-09-17 | Moderna | No |
| 4 | 2022-05-13 | Moderna | No |
| 5 | 2022-09-30 | Moderna | No |
Call center
5 call center cases
5 successful
Free text
Release 2 — days 1–6 daily, dose 1
Systemic reaction (other): Hives 2-3 itchy 1 inch from injection site.
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): Slight increase in anxiety
Systemic reaction (other): Itching other than at the injection site. Response is good to 1% hydrocortisone ointment.
Release 10 — day 35, dose 3
Symptoms: Inflation in deltoid and TMJ Coats syndrome w/ hemangioma in Rt. Eye
Release 11 — days 1–6 daily, dose 4
Systemic reaction (other): Mildly lightheaded
Release 12 — day 28, dose 4
Symptoms: Aneurysm in right eye. New hemorrhaging from it.
Healthcare visit (other): Discovered at monthly retinal checkin.
Release 12 — day 42, dose 4
Release 12 — days 1–6 daily, dose 5
Systemic reaction (other): No
Systemic reaction (other): No
Release 12 — day 7, dose 5
Release 12 — day 28, dose 5
Symptoms: Low grade fever of unknown origin for about 6 days. Tested for Covid. It was negative. No other symptoms other than one episode of diarrhea that resolved in 4 hours.
Release 12 — 3 months, dose 5
Symptoms: Elevated white blood count but I don't believe it's related to the vaccine in any way.
Healthcare visit (other): Follow up blood work
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| HCVO | Unevaluable event | · | · | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Exudative retinopathy | · | · | ✓ |
| SD | Eye haemangioma | · | · | ✓ |
| SD | Eye haemorrhage | · | · | ✓ |
| SD | Irritable bowel syndrome | · | · | ✓ |
| SD | Myositis | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Retinal aneurysm | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | Temporomandibular joint syndrome | · | · | ✓ |
| SD | White blood cell count increased | · | · | ✓ |
| SRO | Anxiety | ✓ | ✓ | ✓ |
| SRO | Dizziness | · | · | ✓ |
| SRO | Injection site pruritus | ✓ | ✓ | ✓ |
| SRO | Injection site urticaria | ✓ | ✓ | ✓ |
| SRO | No adverse event | · | · | ✓ |
| SRO | Pre-existing disease | ✓ | ✓ | ✓ |
| SRO | Self-medication | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release